Ignite Creation Date:
2024-05-06 @ 6:08 PM
Last Modification Date:
2024-10-26 @ 2:42 PM
Study NCT ID:
NCT05551936
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2022-09-19
Brief Title:
A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
Sponsor:
Vaishalee Kenkre
Organization:
Big Ten Cancer Research Consortium
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-19
First Submit QC Date:
September 20 2022
Study First Post Date:
2022-09-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2024-06-05
Last Update Post Date Type:
ACTUAL